Skip to main content
SpringerLink
Log in

Gene Therapy for Autoimmune Disorders

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Although many autoimmune disorders do not have a strong genetic basis, their treatment may nevertheless be improved by gene therapies. Most strategies seek to transfer genes encoding immunomodulatory products that will alter host immune responses in a beneficial manner. Used in this fashion, genes serve as biological delivery vehicles for the products they encode. By this means gene therapy overcomes obstacles to the targeted delivery of proteins and RNA, and improves their efficacy while providing a longer duration of effect, and, potentially, greater safety. Additional genetic strategies include DNA vaccination and the ablation of selected tissues and cell populations. There is considerable evidence from animal studies that gene therapies work: examples include the treatment of experimental models of rheumatoid arthritis, multiple sclerosis, diabetes, and lupus. Pre-clinical success in treating animal models of rheumatoid arthritis has led to the first clinical trial of gene therapy for an autoimmune disease. In this Phase I study, a cDNA encoding the interleukin-1 receptor antagonist was transferred to the knuckle joints of patients with advanced rheumatoid arthritis. Two additional clinical trials are in progress. It is likely that gene therapy will provide effective new treatments for a wide range of autoimmune disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Evans CH, Ghivizzani SC, Whalen JD, Robbins PD: Gene therapy in autoimmune diseases. Ann Rheum Dis 57:125-127, 1998

    Google Scholar 

  2. Evans CH, Thomson AW, Giannoukakis N, Robbins PD: Gene therapy for autoimmune diseases and allograft. In Therapeutic Immunosuppression, AW Thomson (ed). Dordrecht, Kluwer Academic Press, (In Press)

  3. Evans CH, Ghivizzani SC, Kang R, Muzzonigro T, Wasko MC, Herndon JH, Robbins PD: Gene therapy for rheumatic diseases. Arthritis Rheum 42:1-16, 1999

    Google Scholar 

  4. Fathman CG, Costa GL, Seroogy CM: Gene therapy for autoimmune disease [In Process Citation]. Clin Immunol 95:S39-43, 2000

    Google Scholar 

  5. Evans CH, Robbins PD: Gene Therapy in Inflammatory Diseases. Basel, Birkhauser, 2000

    Google Scholar 

  6. Evans CH, Rediske JJ, Abramson SB, Robbins PD: Joint efforts: Tackling arthritis using gene therapy. First International Meeting on the Gene Therapy of Arthritis and Related Disorders. Bethesda, MD, USA, 2–3 December 1998. Mol Med Today 5:148-151, 1999

    Google Scholar 

  7. Evans CH, Robbins PD: Gene therapy of arthritis. Intern Med 38:233-239, 1999

    Google Scholar 

  8. Robbins PD: Gene Therapy Protocols. Totowa, NJ, Humana Press Inc., 1997

    Google Scholar 

  9. Robbins PD, Ghivizzani SC: Viral vectors for gene therapy. Pharmacol Ther 80:35-47, 1998

    Google Scholar 

  10. Powell SK, Kaloss M, Burimski I, Weaver L, Long Z, Lyons R, McGarrity GJ, Otto E: In vitro analysis of transformation potential associated with retroviral vector insertions. Hum Gene Ther 10:2123-2132, 1999

    Google Scholar 

  11. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector [see comments]. Science 272:263-267, 1996

    Google Scholar 

  12. Kessler PD, Podsakoff GM, Chen X, McQuiston SA, Colosi PC, Matelis LA, Kurtzman GJ, Byrne BJ: Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci USA 93:14082-14087, 1996

    Google Scholar 

  13. Fisher KJ, Jooss K, Alston J, Yang Y, Haecker SE, High K, Pathak R, Raper SE, Wilson JM: Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med 3:306-312, 1997

    Google Scholar 

  14. Herzog RW, Hagstrom JN, Kung SH, Tai SJ, Wilson JM, Fisher KJ, High KA: Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc Natl Acad Sci USA 94:5804-5809, 1997

    Google Scholar 

  15. Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D, Gown AM, Winther B, Meuse L, Cohen LK, Thompson AR, Kay MA: Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet 16:270-276, 1997

    Google Scholar 

  16. Restifo NP, Ying H, Hwang L, Leitner WW: The promise of nucleic acid vaccines. Gene Ther 7:89-92, 2000

    Google Scholar 

  17. Youssef S, Wildbaum G, Maor G, Lanir N, Gour-Lavie A, Grabie N, Karin N: Long-lasting protective immunity to experimental autoimmune encephalomyelitis following vaccination with naked DNA encoding C-C chemokines. J Immunol 161:3870-3879, 1998

    Google Scholar 

  18. Youssef S, Wildbaum G, Karin N: Prevention of experimental autoimmune encephalomyelitis by MIP-1alpha and MCP-1 naked DNA vaccines. J Autoimmun 13:21-29, 1999

    Google Scholar 

  19. Wildbaum G, Youssef S, Karin N: A targeted DNA vaccine elicits an immune response to self TNF-alpha and suppresses ongoing adjuvant arthritis. J Immunol (In Press)

  20. Ragno S, Colston MJ, Lowrie DB, Winrow VR, Blake DR, Tascon R: Protection of rats from adjuvant arthritis by immunization with naked DNA encoding for mycobacterial heat shock protein 65. Arthritis Rheum 40:277-283, 1997

    Google Scholar 

  21. Godillot AP, Madaio M, Weiner DB, Williams WV: DNA vaccination as an anti-inflammatory strategy. In Gene Therapy in Inflammatory Diseases, CH Evans, PD Robbins (eds). Basel, Switzerland, Birkhauser Verlag, 2000, pp 205-229

    Google Scholar 

  22. Waisman A, Ruiz PJ, Hirschberg DL, Gelman A, Oksenberg JR, Brocke S, Mor F, Cohen IR, Steinman L: Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity [see comments]. Nat Med 2:899-905, 1996

    Google Scholar 

  23. Finck BK, Linsley PS, Wofsy D: Treatment of murine lupus with CTLA4Ig. Science 265:1225-1227, 1994

    Google Scholar 

  24. Khoury SJ, Akalin E, Chandraker A, Turka LA, Linsley PS, Sayegh MH, Hancock WW: CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J Immunol 155:4521-4524, 1995

    Google Scholar 

  25. Knoerzer DB, Karr RW, Schwartz BD, Mengle-Gaw LJ: Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig. J Clin Invest 96:987-993, 1995

    Google Scholar 

  26. Croxford JL, O'Neill JK, Ali RR, Browne K, Byrnes AP, Dallman MJ, Wood MJ, Fedlmann M, Baker D: Local gene therapy with CTLA4-immunoglobulin fusion protein in experimental allergic encephalomyelitis. Eur J Immunol 28:3904-3916, 1998

    Google Scholar 

  27. Reynolds J, Tam FW, Chandraker A, Smith J, Karkar AM, Cross J, Peach R, Sayegh MH, Pusey CD: CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis. J Clin Invest 105:643-651, 2000

    Google Scholar 

  28. Kawaguchi Y: A gene therapy or purified CTLA4IgG treatment of experimental allergic encephalomyelitis. Hokkaido Igaku Zasshi 74:467-475, 1999

    Google Scholar 

  29. Datta SK, Kalled SL: CD40-CD40 ligand interaction in autoimmune disease. Arthritis Rheum 40:1735-1745, 1997

    Google Scholar 

  30. Samoilova EB, Horton JL, Zhang H, Chen Y: CD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiation. J Mol Med 75:603-608, 1997

    Google Scholar 

  31. Biancone L, Cantaluppi V, Camussi G: CD40-CD154 interaction in experimental and human disease (review). Int J Mol Med 3:343-353, 1999

    Google Scholar 

  32. Howard LM, Miga AJ, Vanderlugt CL, Dal Canto MC, Laman JD, Noelle RJ, Miller SD: Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. J Clin Invest 103:281-290, 1999

    Google Scholar 

  33. Arend WP: Interleukin-1 receptor antagonist. Adv Immunol 54:167-227, 1993

    Google Scholar 

  34. Arend WP, Dayer JM: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 38:151-160, 1995

    Google Scholar 

  35. Shaw MK, Lorens JB, Dhawan A, DalCanto R, Tse HY, Tran AB, Bonpane C, Eswaran SL, Brocke S, Sarvetnick N, Steinman L, Nolan GP, Fathman CG: Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J Exp Med 185:1711-1714, 1997

    Google Scholar 

  36. Mathisen PM, Yu M, Johnson JM, Drazba JA, Tuohy VK: Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J Exp Med 186:159-164, 1997

    Google Scholar 

  37. Chen LZ, Hochwald GM, Huang C, Dakin G, Tao H, Cheng C, Simmons WJ, Dranoff G, Thorbecke GJ: Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta1. Proc Natl Acad Sci USA 95:12516-12521, 1998

    Google Scholar 

  38. Zhang HG, Liu D, Heike Y, Yang P, Wang Z, Wang X, Curiel DT, Zhou T, Mountz JD: Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producing antigen presenting cells [see comments]. Nat Biotechnol 16:1045-1049, 1998

    Google Scholar 

  39. Zhang HG, Fleck M, Kern ER, Liu D, Wang Y, Hsu HC, Yang P, Wang Z, Curiel DT, Zhou T, Mountz JD: Antigen presenting cells expressing Fas ligand down-modulate chronic inflammatory disease in Fas ligand-deficient mice. J Clin Invest 105:813-821, 2000

    Google Scholar 

  40. Le CH, Nicolson AG, Morales A, Sewell KL: Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor alpha receptor gene. Arthritis Rheum 40:1662-1669, 1997

    Google Scholar 

  41. Quattrocchi E, Walmsley M, Browne K, Williams RO, Marinova-Mutafchieva L, Buurman W, Butler DM, Feldmann M: Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis. J Immunol 163:1000-1009, 1999

    Google Scholar 

  42. Apparailly F, Verwaerde C, Jacquet C, Auriault C, Sany J, Jorgensen C: Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J Immunol 160:5213-5220, 1998

    Google Scholar 

  43. Ma Y, Thornton S, Duwel LE, Boivin GP, Giannini EH, Leiden JM, Bluestone JA, Hirsch R: Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer. J Immunol 161:1516-1524, 1998

    Google Scholar 

  44. Kim SH, Evans CH, Kim S, Oligino T, Ghivizzani SC, Robbins PD: Gene therapy of established murine collagen-induced arthritis by local and systemic adenoviral mediated delivery of IL-4. Arthritis Res 2:293-302, 2000

    Google Scholar 

  45. Whalen JD, Lechman EL, Carlos CA, Weiss K, Kovesdi I, Glorioso JC, Robbins PD, Evans CH: Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J Immunol 162:3625-3632, 1999

    Google Scholar 

  46. Song XY, Gu M, Jin WW, Klinman DM, Wahl SM: Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model. J Clin Invest 101:2615-2621, 1998

    Google Scholar 

  47. Shiozawa S, Shimizu K, Tanaka K, Hino K: Studies on the contribution of c-fos/AP-1 to arthritic joint destruction. J Clin Invest 99:1210-1216, 1997

    Google Scholar 

  48. Tomita T, Takeuchi E, Tomita N, Morishita R, Kaneko M, Yamamoto K, Nakase T, Seki H, Kato K, Kaneda Y, Ochi T: Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy. Arthritis Rheum 42:2532-2542, 1999

    Google Scholar 

  49. Miagkov AV, Kovalenko DV, Brown CE, Didsbury JR, Cogswell JP, Stimpson SA, Baldwin AS, Makarov SS: NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci USA 95:13859-13864, 1998

    Google Scholar 

  50. Bessis N, Boissier MC, Ferrara P, Blankenstein T, Fradelizi D, Fournier C: Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur J Immunol 26:2399-2403, 1996

    Google Scholar 

  51. Bessis N, Chiocchia G, Kollias G, Minty A, Fournier C, Fradelizi D, Boissier MC: Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF-alpha)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13 [published erratum appears in Clin Exp Immunol 1998 Jul;113(1):145]. Clin Exp Immunol 111:391-396, 1998

    Google Scholar 

  52. Bessis N, Honiger J, Damotte D, Minty A, Fournier C, Fradelizi D, Boissier M: Encapsulation in hollow fibres of xenogeneic cells engineered to secrete IL-4 or IL-13 ameliorates murine collageninduced arthritis (CIA). Clin Exp Immunol 117:376-382, 1999

    Google Scholar 

  53. Rabinovich GA, Daly G, Dreja H, Tailor H, Riera CM, Hirabayashi J, Chernajovsky Y: Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 190:385-398, 1999

    Google Scholar 

  54. Triantaphyllopoulos KA, Williams RO, Tailor H, Chernajovsky Y: Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy. Arthritis Rheum 42:90-99, 1999

    Google Scholar 

  55. Bessis N, Guery L, Mantovani A, Vecchi A, Sims JE, Fradelizi D, Boissier MC: The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis. Eur J Immunol 30:867-875, 2000

    Google Scholar 

  56. Guery L, Batteux F, Bessis N, Breban M, Boissier MC, Fournier C, Chiocchia G: Expression of Fas ligand improves the effect of IL-4 in collagen-induced arthritis. Eur J Immunol 30:308-315, 2000

    Google Scholar 

  57. Chernajovsky Y, Adams G, Podhajcer OL, Mueller GM, Robbins PD, Feldmann M: Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor receptor. Gene Ther 2:731-735, 1995

    Google Scholar 

  58. Chernajovsky Y, Adams G, Triantaphyllopoulos K, Ledda MF, Podhajcer OL: Pathogenic lymphoid cells engineered to express TGF beta 1 ameliorate disease in a collagen-induced arthritis model. Gene Ther 4:553-559, 1997

    Google Scholar 

  59. Costa GL, Benson JM, Seroogy CM, Achacoso P, Fathman CG, Nolan GP: Targeting rare populations of murine antigen-specific T lymphocytes by retroviral transduction for potential application in gene therapy for autoimmune disease. J Immunol 164:3581-3590, 2000

    Google Scholar 

  60. Annenkov A, Chernajovsky Y: Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta. Gene Ther 7:714-722, 2000

    Google Scholar 

  61. Bandara G, Robbins PD, Georgescu HI, Mueller GM, Glorioso JC, Evans CH: Gene transfer to synoviocytes: prospects for gene treatment of arthritis. DNA Cell Biol 11:227-231, 1992

    Google Scholar 

  62. Evans CH, Robbins PD: Getting genes into human synovium [editorial; comment]. J Rheumatol 24:2061-2063, 1997

    Google Scholar 

  63. Ghivizzani SC, Lechman ER, Tio C, Mule KM, Chada S, McCormack JE, Evans CH, Robbins PD: Direct retrovirusmediated gene transfer to the synovium of the rabbit knee: Implications for arthritis gene therapy. Gene Ther 4:977-982, 1997

    Google Scholar 

  64. Jorgensen C, Demoly P, Noel D, Mathieu M, Piechaczyc M, Gougat C, Bousquet J, Sany J: Gene transfer to human rheumatoid synovial tissue engrafted in SCID mice [see comments]. J Rheumatol 24:2076-2079, 1997

    Google Scholar 

  65. Boyle DL, Nguyen KH, Zhuang S, Shi Y, McCormack JE, Chada S, Firestein GS: Intra-articular IL-4 gene therapy in arthritis: Anti-inflammatory effect and enhanced th2 activity. Gene Ther 6:1911-1918, 1999

    Google Scholar 

  66. Roessler BJ, Allen ED, Wilson JM, Hartman JW, Davidson BL: Adenoviral-mediated gene transfer to rabbit synovium in vivo. J Clin Invest 92:1085-1092, 1993

    Google Scholar 

  67. Sawchuk SJ, Boivin GP, Duwel LE, Ball W, Bove K, Trapnell B, Hirsch R: Anti-T cell receptor monoclonal antibody prolongs transgene expression following adenovirus-mediated in vivo gene transfer to mouse synovium. Hum Gene Ther 7:499-506, 1996

    Google Scholar 

  68. Lubberts E, Joosten LA, van Den Bersselaar L, Helsen MM, Bakker AC, van Meurs JB, Graham FL, Richards CD, van Den Berg WB: Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction. J Immunol 163:4546-4556, 1999

    Google Scholar 

  69. Taniguchi K, Kohsaka H, Inoue N, Terada Y, Ito H, Hirokawa K, Miyasaka N: Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis [see comments]. Nat Med 5:760-767, 1999

    Google Scholar 

  70. Nita I, Ghivizzani SC, Galea-Lauri J, Bandara G, Georgescu HI, Robbins PD, Evans CH: Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo. Arthritis Rheum 39:820-828, 1996

    Google Scholar 

  71. Ghivizzani SC, Lechman ER, Kang R, Tio C, Kolls J, Evans CH, Robbins PD: Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc Natl Acad Sci USA 95:4613-4618, 1998

    Google Scholar 

  72. Pan RY, Xiao X, Chen SL, Li J, Lin LC, Wang HJ, Tsao YP: Disease-inducible transgene expression from a recombinant adeno-associated virus vector in a rat arthritis model. J Virol 73:3410-3417, 1999

    Google Scholar 

  73. Goater J, Muller R, Kollias G, Firestein GS, Sanz I, O'Keefe RJ, Schwarz EM: Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis [In Process Citation]. J Rheumatol 27:983-989, 2000

    Google Scholar 

  74. Pan RY, Chen SL, Xiao X, Liu DW, Peng HJ, Tsao YP: Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist. Arthritis Rheum 43:289-297, 2000

    Google Scholar 

  75. Oligino T, Ghivizzani S, Wolfe D, Lechman E, Krisky D, Mi Z, Evans C, Robbins P, Glorioso J: Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis. Gene Ther 6:1713-1720, 1999

    Google Scholar 

  76. Yovandich J, O'Malley B, Jr., Sikes M, Ledley FD: Gene transfer to synovial cells by intra-articular administration of plasmid DNA. Hum Gene Ther 6:603-610, 1995

    Google Scholar 

  77. Miyata M, Sato Y, Kasukawa R: Naked DNA as a gene delivery vehicle in inflammatory diseases. In Gene Therapy in Inflammatory Diseases, CH Evans, PD Robbins (eds). Basel, Switzerland, Burkhauser Verlag, 2000, pp 231-239

    Google Scholar 

  78. Tomita T, Hashimoto H, Tomita N, Morishita R, Lee SB, Hayashida K, Nakamura N, Yonenobu K, Kaneda Y, Ochi T: In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (Sendai virus) and liposomes. Arthritis Rheum 40:901-906, 1997

    Google Scholar 

  79. Lechman ER, Jaffurs D, Ghivizzani SC, Gambotto A, Kovesdi I, Mi Z, Evans CH, Robbins PD: Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees. J Immunol 163:2202-2208, 1999

    Google Scholar 

  80. Takayanagi H, Juji T, Miyazaki T, Iizuka H, Takahashi T, Isshiki M, Okada M, Tanaka Y, Koshihara Y, Oda H, Kurokawa T, Nakamura K, Tanaka S: Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts. J Clin Invest 104:137-146, 1999

    Google Scholar 

  81. Evans CH, Ghivizzani SC, Lechman E, Mi Z, Jaffurs D, Robbins PD: Lessons learned from gene transfer approaches. Arthritis Res http://arthritis-research.com/08jul99/ar0101r01, 1999

  82. Mi Z, Ghivizzani SC, Lechman ER, Jaffurs D, Glorioso JC, Evans CH, Robbins PD: Adenoviral mediated gene transfer of IGF-1 stimulates cartilage synthesis in rabbit joints. Arthritis Rheum, (In Press)

  83. Shuler FD, Georgescu HI, Niyibizi C, Studer RK, Mi Z, Johnstone B, Robbins PD, Evans CH: Increased matrix synthesis following adenoviral transfer of a transforming growth factor beta-1 gene into articular chondrocytes. J Orthop Res, (In Press)

  84. Smith P, Shuler FR, Georgescu HI, Ghivizzani SC, Johnstone B, Niyibizi C, Robbins PD, Evans CH: Genetic enhancement of matrix synthesis by articular chondrocytes: Comparison of different growth factors in the presence and absence of interleukin-1. Arthritis Rheum 43:1156-1164, 2000

    Google Scholar 

  85. Ghivizzani SC, Kang R, Georgescu HI, Lechman ER, Jaffurs D, Engle JM, Watkins SC, Tindal MH, Suchanek MK, McKenzie LR, Evans CH, Robbins PD: Constitutive intra-articular expression of human IL-1 beta following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis. J Immunol 159:3604-3612, 1997

    Google Scholar 

  86. Oligino TA, Yao Q, Xiao X, Glorioso JC, Evans CH, Robbins PD, Ghivizzani SC: Intraarticular expression of the IL-1Ra gene following direct delivery with an adeno-associated virus vector. Gene Ther (In Press)

  87. Sant SM, Suarez TM, Moalli MR, Wu BY, Blaivas M, Laing TJ, Roessler BJ: Molecular lysis of synovial lining cells by in vivo herpes simplex virus-thymidine kinase gene transfer. Hum Gene Ther 9:2735-2743, 1998

    Google Scholar 

  88. Goossens PH, Schouten GJ, t Hart BA, Bout A, Brok HP, Kluin PM, Breedveld FC, Valerio D, Huizinga TW: Feasibility of adenovirus-mediated nonsurgical synovectomy in collageninduced arthritis-affected rhesus monkeys. Hum Gene Ther 10:1139-1149, 1999

    Google Scholar 

  89. Yao Q, Glorioso JC, Evans CH, Robbins PD, Oligino TJ, Ghivizzani SC: Adenoviral mediated delivery of FAS ligand to rheumatoid synovium results in extensive apoptosis in the synovial lining. J. Gene Med (In Press)

  90. Zhang H, Yang Y, Horton JL, Samoilova EB, Judge TA, Turka LA, Wilson JM, Chen Y: Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer. J Clin Invest 100:1951-1957, 1997

    Google Scholar 

  91. Kobayashi T, Okamoto K, Kobata T, Hasunuma T, Kato T, Hamada H, Nishioka K: Novel gene therapy for rheumatoid arthritis by FADD gene transfer: Induction of apoptosis of rheumatoid synoviocytes but not chondrocytes. Gene Ther 7:527-533, 2000

    Google Scholar 

  92. Bandara G, Mueller GM, Galea-Lauri J, Tindal MH, Georgescu HI, Suchanek MK, Hung GL, Glorioso JC, Robbins PD, Evans CH: Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci USA 90:10764-10768, 1993

    Google Scholar 

  93. Hung GL, Galea-Lauri J, Mueller GM, Georgescu HI, Larkin LA, Suchanek MK, Tindal MH, Robbins PD, Evans CH: Suppression of intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium. Gene Ther 1:64-69, 1994

    Google Scholar 

  94. Otani K, Nita I, Macaulay W, Georgescu HI, Robbins PD, Evans CH: Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J Immunol 156:3558-3562, 1996

    Google Scholar 

  95. Makarov SS, Olsen JC, Johnston WN, Anderle SK, Brown RR, Baldwin AS, Jr., Haskill JS, Schwab JH: Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Proc Natl Acad Sci USA 93:402-406, 1996

    Google Scholar 

  96. Bakker AC, Joosten LA, Arntz OJ, Helsen MM, Bendele AM, van de Loo FA, van den Berg WB: Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum 40:893-900, 1997

    Google Scholar 

  97. Muller-Ladner U, Roberts CR, Franklin BN, Gay RE, Robbins PD, Evans CH, Gay S: Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective. J Immunol 158:3492-3498, 1997

    Google Scholar 

  98. Muller-Ladner U, Evans CH, Franklin BN, Roberts CR, Gay RE, Robbins PD, Gay S: Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model. Arthritis Rheum 42:490-497, 1999

    Google Scholar 

  99. Decaris E, Guingamp C, Chat M, Philippe L, Grillasca JP, Abid A, Minn A, Gillet P, Netter P, Terlain B: Evidence for neurogenic transmission inducing degenerative cartilage damage distant from local inflammation. Arthritis Rheum 42:1951-1960, 1999

    Google Scholar 

  100. Whalen JD, Lu L, Thomson AW, Robbins PD, Evans CH: Transfer and expression of the viral IL-10 gene in vivo induces a suppressor population of antigen presenting cells which adoptively transfer suppression to soluble antigens; evidence for involvement of dendritic cells and macrophages. Submitted, 2000

  101. Frisbie D, Robbins PD, Evans CH, McIlwraith CW: In vivo gene therapy of an equine model of osteoarthritis (Submitted)

  102. Clackson T: Regulated gene expression systems. Gene Ther 7:120-125, 2000

    Google Scholar 

  103. Varley AW, Geiszler SM, Gaynor RB, Munford RS: A twocomponent expression system that responds to inflammatory stimuli in vivo. Nat Biotechnol 15:1002-1006, 1997

    Google Scholar 

  104. Evans CH, Robbins PD, Ghivizzani SC, Herndon JH, Kang R, Bahnson AB, Barranger JA, Elders EM, Gay S, Tomaino MM, Wasko MC, Watkins SC, Whiteside TL, Glorioso JC, Lotze MT, Wright TM: Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther 7:1261-1280, 1996

    Google Scholar 

  105. Muzzonigro TS, Kang R, Reinecke J, Wehling P, Wasko MC, Herndon JH: Gene therapy for rheumatoid arthritis: clinical studies. In Gene Therapy in Inflammatory Diseases, CH Evans, PD Robbins (eds). Basle, Switzerland, Birkhauser Verlag, 2000, pp 53-63

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Molecular Orthopaedics, Department of Orthopaedic Surgery, Harvard Medical School, Boston, Massachusetts, 02115

    C. H. Evans & S. C. Ghivizzani

  2. Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

    T. J. Oligino & P. D. Robbins

Authors
  1. C. H. Evans
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. C. Ghivizzani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. J. Oligino
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. D. Robbins
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Evans, C.H., Ghivizzani, S.C., Oligino, T.J. et al. Gene Therapy for Autoimmune Disorders. J Clin Immunol 20, 334–346 (2000). https://doi.org/10.1023/A:1006616029205

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006616029205

Search

Navigation